Matthew S. Hayden

Cited by

	All	Since 2019
Citations	31551	10277
h-index	38	31
i10-index	57	44

2200

1100

550

1650

20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024108 127 204 493 848 831 970 1174 1369 1529 1827 1948 2041 2029 1968 1785 1768 1814 1929 2110 1953 1743 728

Public access

View all

34 articles

1 article

available

not available

Based on funding mandates

Co-authors

Sankar Ghoshyale OR hhmi OR columbia OR einstein OR whiteheadVerified email at columbia.edu
Richard A. FlavellSterling Professor of Immunobiology, Yale University, HHMI InvestigatorVerified email at yale.edu
Park Sung-GyooSeoul National UniversityVerified email at snu.ac.kr
A. Phillip WestThe Jackson LaboratoryVerified email at jax.org
Matthew Blake GreenblattWeill Cornell MedicineVerified email at med.cornell.edu
Ulf KleinUniversity of Leeds, U.K.Verified email at leeds.ac.uk
Shizuo AkiraOsaka UniversityVerified email at biken.osaka-u.ac.jp
Changchun XiaoSanofi Institute for Biomedical Research (SIBR), Suzhou, ChinaVerified email at scripps.edu
Joseph M. McCuneProfessor of Medicine, University of California, San FranciscoVerified email at ucsf.edu
Guolong "Glenn" ZhangRegents Professor, Oklahoma State UniversityVerified email at okstate.edu
Charles SerhanBrigham & Women's Hospital Harvard Medical SchoolVerified email at zeus.bwh.harvard.edu
Shannon Terrell BaileyFoundation Medicine, Inc.Verified email at foundationmedicine.com
Jason D. Barbour, PhDChief Executive Officer & Technical Founder, Simpatica Medicine, Inc.Verified email at simpaticamedicine.com
Kenji KabashimaKyoto UniversityVerified email at kuhp.kyoto-u.ac.jp
Raul RabadanProfessor, Columbia UniversityVerified email at cumc.columbia.edu
Fulvio D'AcquistoProfessor of Immunology, University of RoehamptonVerified email at roehampton.ac.uk
Alexander HoffmannUCLAVerified email at ucla.edu
Hediye Erdjument-BromageProteomics Core Manager, Memorial Sloan-Kettering Cancer Center, New York, NY, USAVerified email at ski.mskcc.org
Brigid HoganDuke Medical SchoolVerified email at duke.edu
Sitharam RamaswamiSt Johns University, Columbia University, NYU Langone Medical CenterVerified email at nyumc.org

Matthew S. Hayden

Assistant Professor of Dermatology, Geisel School of Medicine, Dartmouth-Hitchcock

Verified email at hitchcock.org - Homepage

Cutaneous Malignancy Inflammation Cell Signaling Oncoviruses


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Shared principles in NF-κB signaling MS Hayden, S Ghosh Cell 132 (3), 344-362, 2008	5614	2008
Signaling to NF-κB MS Hayden, S Ghosh Genes & development 18 (18), 2195-2224, 2004	5188	2004
NF-κB, inflammation, and metabolic disease RG Baker, MS Hayden, S Ghosh Cell metabolism 13 (1), 11-22, 2011	2163	2011
Crosstalk in NF-κB signaling pathways A Oeckinghaus, MS Hayden, S Ghosh Nature immunology 12 (8), 695-708, 2011	2057	2011
NF-κB, the first quarter-century: remarkable progress and outstanding questions MS Hayden, S Ghosh Genes & development 26 (3), 203-234, 2012	2037	2012
New regulators of NF-κB in inflammation S Ghosh, MS Hayden Nature Reviews Immunology 8 (11), 837-848, 2008	1594	2008
A toll-like receptor that prevents infection by uropathogenic bacteria D Zhang, G Zhang, MS Hayden, MB Greenblatt, C Bussey, RA Flavell, ... Science 303 (5663), 1522-1526, 2004	1580	2004
NF-κ B and the immune response MS Hayden, AP West, S Ghosh Oncogene 25 (51), 6758-6780, 2006	1573	2006
TLR11 activation of dendritic cells by a protozoan profilin-like protein F Yarovinsky, D Zhang, JF Andersen, GL Bannenberg, CN Serhan, ... Science 308 (5728), 1626-1629, 2005	1344	2005
NF-κB in immunobiology MS Hayden, S Ghosh Cell research 21 (2), 223-244, 2011	1097	2011
Regulation of NF-κB by TNF family cytokines MS Hayden, S Ghosh Seminars in immunology 26 (3), 253-266, 2014	1045	2014
TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo JH Shim, C Xiao, AE Paschal, ST Bailey, P Rao, MS Hayden, KY Lee, ... Genes & development 19 (22), 2668-2681, 2005	885	2005
Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia SG Deeks, T Wrin, T Liegler, R Hoh, M Hayden, JD Barbour, NS Hellmann, ... New England Journal of Medicine 344 (7), 472-480, 2001	861	2001
Nuclear factor-κB modulates regulatory T cell development by directly regulating expression of Foxp3 transcription factor M Long, SG Park, I Strickland, MS Hayden, S Ghosh Immunity 31 (6), 921-931, 2009	467	2009
Recognition of profilin by Toll-like receptor 12 is critical for host resistance to Toxoplasma gondii AA Koblansky, D Jankovic, H Oh, S Hieny, W Sungnak, R Mathur, ... Immunity 38 (1), 119-130, 2013	419	2013
PDK1 nucleates T cell receptor-induced signaling complex for NF-κB activation KY Lee, F D'acquisto, MS Hayden, JH Shim, S Ghosh Science 308 (5718), 114-118, 2005	311	2005
PDK1 nucleates T cell receptor-induced signaling complex for NF-κB activation KY Lee, F D'Acquisto, MS Hayden, JH Shim, S Ghosh Science 308 (5718), 114-118, 2005	311	2005
PDK1 nucleates T cell receptor-induced signaling complex for NF-kB activation KY Lee, F D’Acquisto, MS Hayden, JH Shim, S Ghosh Science, 114-118, 0	311*
Celebrating 25 years of NF‐κB research S Ghosh, MS Hayden Immunological reviews 246 (1), 5-13, 2012	272	2012
NF-κB c-Rel Is Crucial for the Regulatory T Cell Immune Checkpoint in Cancer Y Grinberg-Bleyer, H Oh, A Desrichard, DM Bhatt, R Caron, TA Chan, ... Cell 170 (6), 1096-1108. e13, 2017	270	2017

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors